Anti-inflammatory Effect of Ghrelin in Lymphoblastoid Cell Lines From Children With Autism Spectrum Disorder
Open Access
- 26 March 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 10, 152
Abstract
The gut hormone ghrelin has been implicated in a variety of functional roles in the central nervous system through the brain-gut axis, one of which is an anti-inflammatory effect. An aberrant brain-gut axis producing immune dysfunction has been implicated in the pathobiology of autism spectrum disorder (ASD), and elevated expression of inflammatory markers has been shown in blood and brain tissue from subjects with ASD. We hypothesized that ghrelin may mitigate this effect. Lymphoblastoid cell lines from typically developed children (TD-C) (N = 20) and children with ASD (ASD-C) (N = 20) were cultured with PBS or human ghrelin (0.01 μM) for 24 h, and mRNA expression levels of the inflammation-related molecules interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and nuclear factor kappa B (NF-κB) were measured to examine the effects of ghrelin as an anti-inflammatory agent. Expression levels of TNF-α and NF-κB mRNA, but not IL-1β or IL-6, were significantly elevated in ASD-C compared to TD-C. Ghrelin showed a tendency to reduce the expression of TNF-α and NF-κB, but this was not statistically significant. Considering the heterogenous pathobiology of ASD, we examined the effects of ghrelin on TD-C and ASD-C with expression levels of TNF-α and NF-κB in the highest and lowest quartiles. We found that ghrelin markedly reduced mRNA expression of TNF-α and NF-κB s in ASD-C with highest-quartile expression, but there were no effects in ASD-C with lowest-quartile expression, TD-C with highest quartile expression, or TD-C with lowest quartile expression. Together, these findings suggest that ghrelin has potential as a novel therapeutic agent for ASD with inflammation and/or immune dysfunction.Keywords
This publication has 50 references indexed in Scilit:
- NF-B Signaling in the Brain of Autistic SubjectsMediators of Inflammation, 2011
- Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum DisordersPLOS ONE, 2011
- A Study of Nuclear Transcription Factor-Kappa B in Childhood AutismPLOS ONE, 2011
- Aberrant NF-KappaB Expression in Autism Spectrum Condition: A Mechanism for NeuroinflammationFrontiers in Psychiatry, 2011
- Neurodevelopmental effects of chronic exposure to elevated levels of pro-inflammatory cytokines in a developing visual systemNeural Development, 2010
- Elevated immune response in the brain of autistic patientsJournal of Neuroimmunology, 2009
- Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathwaysSurgery, 2008
- Cerebrospinal Fluid and Serum Markers of Inflammation in AutismPediatric Neurology, 2005
- Neuroglial activation and neuroinflammation in the brain of patients with autismAnnals of Neurology, 2004
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999